ALYCE WILLIAMS: Open Payments
NPI 1215579644 · TEMPLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$735 in 30 payments from 7 companies in 2025. Trend: 2023 $762 · 2024 $546 · 2025 $735
Food & beverage: $626Education: $109
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 12 | $343 |
| Neurocrine BioSciences, Inc. | 4 | $101 |
| Janssen Pharmaceuticals, Inc | 4 | $91 |
| Alkermes, Inc. | 4 | $83 |
| E.R. Squibb & Sons, L.L.C. | 3 | $55 |
| ABBVIE INC. | 2 | $41 |
| Lundbeck LLC | 1 | $21 |
Products named: UZEDY, INGREZZA, INVEGA SUSTENNA, ARISTADA, COBENFY, VRAYLAR, LYBALVI, ABILIFY ASIMTUFII.
Industry payments across TX — which companies pay providers there.
